Evaluation of the Anti-inflammatory Effect of Aqueous Extract of Pistacia atlantica Gum in an Experimental Model of Ulcerative Colitis

Evaluation of the Anti-inflammatory Effect of Aqueous Extract of Pistacia atlantica Gum in an Experimental Model of Ulcerative Colitis

Introduction: Ulcerative colitis is a chronic inflammatory bowel disease. Immunosuppressive drugs and various salicylates improve the disease activity index in individuals with ulcerative colitis. Nonetheless, drug resistance and the side effects of these medications drive researchers toward designi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shabnam Bahrami, Nahid Babaei, Hadi Esmaeili Gouvarchin Ghaleh, Jaleh Mohajeri Borazjani, Mahdieh Farzanehpour
Format:	Article
Language:	fas
Published:	Arak University of Medical Sciences 2024-04-01
Series:	Complementary Medicine Journal of Faculty of Nursing and Midwifery
Subjects:	baneh plant inflammation inflammatory cytokines mesalazine ulcerative colitis
Online Access:	http://cmja.arakmu.ac.ir/article-1-968-en.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis
by: Yu. P. Uspenskiy, et al.
Published: (2022-03-01)

Mesalazin-induced eosinophilic pneumonia in a 15-year-old boy with ulcerative colitis
by: G. N. Yankinа, et al.
Published: (2019-10-01)

The impact of low-dose Fructooligosaccharide combined with Mesalazine on inflammation levels and therapeutic effects in elderly patients with ulcerative colitis
by: Wang Fangfang, et al.
Published: (2025-07-01)

Drug-Induced Lung Disease (Organizing Pneumonia) Associated with Mesalazine
by: E. V. Smirnova, et al.
Published: (2022-02-01)

Optimization of approaches to the treatment of mild to moderate ulcerative colitis
by: S. S. Belous, et al.
Published: (2021-09-01)

Features of rectal treatment of inflammatory bowel diseases
by: D. V. Egorov, et al.
Published: (2023-07-01)

Clinical observation of probiotics combined with mesalazine and Yiyi Baitouweng Decoction retention enema in treating mild-to-moderate ulcerative colitis
by: Li Yanlong, et al.
Published: (2025-02-01)

Anti-inflammatory effects of calcitriol-treated mesenchymal stem cells on experimental ulcerative colitis
by: Hossein Abdi, et al.
Published: (2021-12-01)

Modern principles of conservative treatment of mild and moderate forms of ulcerative colitis
by: O. V. Golovenko
Published: (2022-11-01)

Colon-Targeted Poly(ADP-ribose) Polymerase Inhibitors Synergize Therapeutic Effects of Mesalazine Against Rat Colitis Induced by 2,4-Dinitrobenzenesulfonic Acid
by: Changyu Kang, et al.
Published: (2024-12-01)

Effective domestic mesalazine in the therapy of ulcerative colitis
by: I. N. Ruchkina, et al.
Published: (2021-06-01)

Effects of Yunnan Baiyao retention enema combined with mesalazine enteric-coated tablets and bifidobacterium triple viable capsules for treating ulcerative colitis
by: Liu Junjie, et al.
Published: (2022-04-01)

Clinical efficacy study of Qingre Huashi Yuyang formula combined with mesalazine entericcoated tablets in the treatment of damp-heat ulcerative colitis of large intestine: a randomized clinical trial
by: Hu Xiaojuan, et al.
Published: (2024-10-01)

The Changes evolved in the Spatial Organization at Border Regions: With special emphasis on the role played by acting agents A Case Study on: Baneh and its peripheries
by: Mehdi Razpour
Published: (2021-11-01)

4-aminosalicylic acid as a coupling reagent for spectrophotometric determination of mesalazine in an aqueous medium
by: Mohamed Y. Dhamra, et al.
Published: (2024-06-01)

Green synthesis of superhydrophobic cotton filters using Pistacia atlantica gum for efficient oil and water separation
by: Zahra Seifi, et al.
Published: (2025-04-01)

Evaluation of the antitumor effects of Echovirus in combination with Doxorubicin in a mouse model of breast cancer
by: Fatemeh Aminian, et al.
Published: (2025-06-01)

Tailoring Mesalazine Nanosuspension Using Chitosan Polyelectrolyte Complexes with Alginate and Alginate/Hydroxypropyl-Methylcellulose Phthalate
by: Amélia Aparecida Rocca Pereira, et al.
Published: (2024-11-01)

Diverticular disease of the large intestine: current state of the problem
by: N. A. Lysov, et al.
Published: (2020-12-01)

Mesalazine and Lactoferrin as Potential Adjuvant Therapy in Colorectal Cancer: Effects on Cell Viability and Wnt/β-Catenin Pathway
by: Joanna Słoka, et al.
Published: (2025-05-01)

Protective Effect of Peach Gum Polysaccharides on DSS-induced Ulcerative Colitis in Mice
by: Rui DING, et al.
Published: (2025-07-01)

Evaluation of Antibacterial and Antifungal Activity of Pistacia atlantica Subsp. kurdica Oil Gum Extract from Halabja Province/ Kurdistan Region of Iraq
by: Peshawa Y. Aziz, et al.
Published: (2022-08-01)

Chemical Composition of Iran's Pistacia atlantica Cold-Pressed Oil
by: M. Saber-Tehrani, et al.
Published: (2013-01-01)

Terminal ileitis: Questions of differential diagnosis and prospects for treatment. A review
by: Alexey M. Osadchuk, et al.
Published: (2025-01-01)

Radiation-induced morphea of the breast – characterization and treatment of fibroblast dysfunction with repurposed mesalazine
by: Stephan R. Künzel, et al.
Published: (2024-10-01)

Microscopic Colitis: A Clinical Case
by: E. V. Reznik, et al.
Published: (2023-04-01)

Clinical and morphological approaches to the differential diagnosis of diphtheric colitis
by: V. A. Tsinserling, et al.
Published: (2015-07-01)

Pharmacogenetics and Inflammatory Bowel Diseases in Adults and Children: Diagnosis and Treatment Prospects
by: S. Yu. Serebrova, et al.
Published: (2020-05-01)

Molecular Mechanisms and Clinical Aspects of Colitis-Associated Cancer in Ulcerative Colitis
by: Jesus K. Yamamoto-Furusho, et al.
Published: (2025-01-01)

Potential role of upadacitinib in cytomegalovirus colitis recurrence
by: Kaito Tsujinaka, et al.
Published: (2025-04-01)

Mesalazine: a novel therapeutic agent for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis
by: Yuqi Wang, et al.
Published: (2025-01-01)

Correction: Mesalazine: a novel therapeutic agent for periodontitis via regulation of periodontal microbiota and inhibiting Porphyromonas gingivalis
by: Frontiers Production Office
Published: (2025-07-01)

Amelioration of inflammatory bowel disease by Bifidobacterium animalis subsp. lactis XLTG11 in combination with mesalazine
by: Weiwei Ma, et al.
Published: (2024-12-01)

PROTON-PUMP INHIBITORS ARE ASSOCIATED WITH AN INCREASED RISK OF MICROSCOPIC COLITIS: A POPULATION-BASED STUDY AND REVIEW OF THE LITERATURE
by: Rashid ABDEL-RAZEQ, et al.
Published: (2024-10-01)

Spectrophotometric Determination of Mesalazine in Pharmaceutical Preparations by Oxidative Coupling Reactions with m-Aminophenol and 2,6- Dihydroxybenzoic Acid
by: Aziz et al.
Published: (2019-12-01)

Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review
by: Pan J, et al.
Published: (2025-01-01)

Endoscopic and clinicopathological features of segmental colitis associated with diverticulosis
by: Kazuhiko Obata, et al.
Published: (2024-04-01)

Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres
by: David Young, et al.
Published: (2025-01-01)

Advances in surgical treatment of ulcerative colitis associated colorectal cancer
by: He-Yuan NIU, et al.
Published: (2023-12-01)

Dermatomiositis y colitis ulcerosa: presentación de un caso
by: Pedro Rosales Torres, et al.
Published: (2019-04-01)